Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.

Stefanini B, Piscaglia F, Marra F, Iavarone M, Vivaldi C, Cabibbo G, Palloni A, Pressiani T, Dalbeni A, Stefanini B, Stella L, Federico P, Svegliati-Baroni G, Lonardi S, Soldà C, Ielasi L, De Lorenzo S, Garajova I, Campani C, Bruccoleri M, Masi G, Celsa C, Brandi G, Auriemma A, Daniele B, Ponziani FR, Lani L, Chen R, Boe M, Granito A, Rimassa L, Tovoli F, ARTE study group

Open source

DOI: 10.1159/000545494
Published: 2026 Feb
Container: Liver cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000545494,
  title = {Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.},
  author = {Stefanini B and Piscaglia F and Marra F and Iavarone M and Vivaldi C and Cabibbo G and Palloni A and Pressiani T and Dalbeni A and Stefanini B and Stella L and Federico P and Svegliati-Baroni G and Lonardi S and Soldà C and Ielasi L and De Lorenzo S and Garajova I and Campani C and Bruccoleri M and Masi G and Celsa C and Brandi G and Auriemma A and Daniele B and Ponziani FR and Lani L and Chen R and Boe M and Granito A and Rimassa L and Tovoli F and ARTE study group},
  year = {2026},
  journal = {Liver cancer},
  doi = {10.1159/000545494},
  url = {https://doi.org/10.1159/000545494}
}

RIS

TY  - JOUR
TI  - Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.
AU  - Stefanini B
AU  - Piscaglia F
AU  - Marra F
AU  - Iavarone M
AU  - Vivaldi C
AU  - Cabibbo G
AU  - Palloni A
AU  - Pressiani T
AU  - Dalbeni A
AU  - Stefanini B
AU  - Stella L
AU  - Federico P
AU  - Svegliati-Baroni G
AU  - Lonardi S
AU  - Soldà C
AU  - Ielasi L
AU  - De Lorenzo S
AU  - Garajova I
AU  - Campani C
AU  - Bruccoleri M
AU  - Masi G
AU  - Celsa C
AU  - Brandi G
AU  - Auriemma A
AU  - Daniele B
AU  - Ponziani FR
AU  - Lani L
AU  - Chen R
AU  - Boe M
AU  - Granito A
AU  - Rimassa L
AU  - Tovoli F
AU  - ARTE study group
PY  - 2026
JO  - Liver cancer
DO  - 10.1159/000545494
UR  - https://doi.org/10.1159/000545494
ER  -

APA

B, S., F, P., F, M., M, I., C, V., G, C., A, P., T, P., A, D., B, S., L, S., P, F., G, S., S, L., C, S., L, I., S, D. L., I, G., C, C., M, B., G, M., C, C., G, B., A, A., B, D., FR, P., L, L., R, C., M, B., A, G., L, R., F, T., & group, A. S. (2026). Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.. Liver cancer. https://doi.org/10.1159/000545494

Source records

pubmed · retrieved 2026-09-25T13:36:24.669Z